Jessica A Walsh Selected Research

Jessica A Walsh Research Topics

Disease

15	Psoriatic Arthritis 10/2023 - 08/2014
11	Ankylosing Spondylitis 11/2023 - 01/2014
11	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 12/2013
9	Axial Spondyloarthritis 01/2023 - 01/2020
6	Pain (Aches) 02/2024 - 08/2014
4	Arthritis (Polyarthritis) 03/2024 - 01/2018
3	Back Pain (Backache) 01/2023 - 08/2014
3	Sacroiliitis 01/2023 - 01/2017
3	Fatigue 10/2020 - 08/2014
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 05/2019
2	Non-Radiographic Axial Spondyloarthritis 08/2023 - 01/2022
2	Mood Disorders (Mood Disorder) 05/2023 - 01/2020
2	Frailty 01/2023 - 11/2021
2	Uveitis 11/2020 - 06/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2020 - 06/2018
2	Inflammation (Inflammations) 01/2020 - 12/2012
2	Necrosis 01/2020 - 01/2014
2	Rheumatoid Arthritis 01/2018 - 01/2016
1	Body Weight (Weight, Body) 01/2024
1	Dyspnea (Shortness of Breath) 01/2023
1	Spondylarthritis (Spinal Arthritis) 01/2022
1	Low Back Pain (Lumbago) 11/2020
1	Chronic Disease (Chronic Diseases) 10/2020
1	COVID-19 01/2020
1	Bronchiectasis 01/2020
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2019
1	Osteoarthritis 01/2019
1	Crohn Disease (Crohn's Disease) 06/2018
1	Ulcerative Colitis 06/2018
1	Optic Nerve Diseases (Optic Neuropathy) 01/2014
1	Obstructive Sleep Apnea 12/2012

Drug/Important Bio-Agent (IBA)

7	Antirheumatic Agents (DMARD)IBA 03/2024 - 01/2018
7	Tumor Necrosis Factor InhibitorsIBA 01/2023 - 12/2012
6	ixekizumabIBA 01/2023 - 09/2019
5	Adalimumab (Humira)FDA Link 01/2021 - 01/2014
3	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2023 - 08/2014
3	Interleukin-17 (Interleukin 17)IBA 01/2023 - 09/2019
3	golimumab FDA Link 09/2021 - 01/2016
3	Certolizumab Pegol FDA Link 01/2020 - 01/2016
3	Etanercept (Enbrel)FDA Link 01/2020 - 01/2016
2	upadacitinibIBA 10/2023 - 08/2023
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023 - 12/2012
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2023 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2021
2	ametantrone (HAQ)IBA 01/2023 - 01/2021
2	Ustekinumab (CNTO 1275)FDA Link 01/2020 - 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	InterleukinsIBA 10/2023
1	Janus KinasesIBA 10/2023
1	Janus Kinase InhibitorsIBA 10/2023
1	C-Reactive ProteinIBA 01/2023
1	secukinumabIBA 01/2023
1	guselkumabIBA 01/2022
1	AS 8IBA 09/2021
1	Interleukin-12 (IL 12)IBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2020
1	SuspensionsIBA 01/2020
1	TabletsIBA 01/2020
1	Oxygen (Dioxygen)IBA 05/2019
1	Phospholipase DIBA 01/2019
1	TubulinIBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	HLA-B Antigens (HLA-B)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	GTP Phosphohydrolases (GTPases)IBA 01/2019
1	Prostaglandins AIBA 01/2018
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2017
1	tocilizumab (atlizumab)FDA Link 01/2016
1	Abatacept (Orencia)FDA Link 01/2016
1	Infliximab (Remicade)FDA Link 01/2016
1	Rituximab (Mabthera)FDA Link 01/2016

Therapy/Procedure

13	Therapeutics 02/2024 - 12/2013
3	Biological Therapy 01/2020 - 03/2018
1	Activities of Daily Living (ADL) 01/2023
1	Injections 01/2020